Fertility clinics must end unproven treatments that don't help couples have babies
Fertility clinics should not offer unproven treatments that don't help people have babies, our independent committee has recommended in draft guidance.
News, blogs and podcasts
Latest articles
First NICE-curated guideline announced ahead of World Duchenne Awareness Day
In the lead-up to World Duchenne Awareness Day on Sunday 7 September, we’re pleased to announce the completion of our first assessment of an externally developed clinical guideline.
Breakthrough life-extending combination treatment for advanced bladder cancer recommended by NICE
The new treatment offers hope to thousands living with advanced urothelial cancer, with clinical trials showing overall survival rates were almost twice as long compared to standard treatment.
Biggest shake-up in type 2 diabetes care in a decade announced
Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments – the biggest shake-up in care for a decade – as part of NICE’s commitment to re-evaluate priority clinical pathways described in the 10-Year Health Plan for the NHS.
Latest in-depth
We've published our annual report and accounts for 2024 to 2025
Our annual report and accounts summarise our key achievements from April 2024 to March 2025.
Strengthening Egypt's healthcare system through technology assessment
NICE International has helped Egypt take a crucial step towards a fairer, more efficient healthcare system.
Latest blogs
Strengthening health systems across the globe
How NICE International is supporting evidence-based decision-making through the Regulatory Partnership for Growth Fund
NICE responds to publication of the government’s Life Sciences Sector Plan
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
Latest podcasts
Treating type 2 diabetes with SGLT-2 inhibitors
Innovation in action: Inside NICE's HTA Lab
